UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat associated disease

Fautsch, MP; Wieben, ED; Baratz, KH; Bhattacharyya, N; Sadan, AN; Hafford-Tear, NJ; Tuft, SJ; (2020) TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat associated disease. Progress in Retinal and Eye Research , Article 100883. 10.1016/j.preteyeres.2020.100883. (In press). Green open access

[thumbnail of Davidson_TCF4-mediated Fuchs endothelial corneal dystrophy- Insights into a common trinucleotide repeat associated disease_Pre-Proof.pdf]
Preview
Text
Davidson_TCF4-mediated Fuchs endothelial corneal dystrophy- Insights into a common trinucleotide repeat associated disease_Pre-Proof.pdf - Accepted Version

Download (24MB) | Preview

Abstract

Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in the elderly. Since the first description of an association between FECD and common polymorphisms situated within the transcription factor 4 (TCF4) gene, genetic and molecular studies have implicated an intronic CTG trinucleotide repeat expansion (CTG18.1) as a causal variant in the majority of FECD patients. To date, several non-mutually exclusive mechanisms have been proposed that drive and/or exacerbate the onset of disease. These mechanisms include (i) TCF4 dysregulation; (ii) toxic gain-of-function from TCF4 repeat-containing RNA; (iii) toxic gain-of-function from repeat-associated non-AUG dependent (RAN) translation; and (iv) somatic instability of CTG18.1. However, the relative contribution of these proposed mechanisms in disease pathogenesis is currently unknown. In this review, we summarise research implicating the repeat expansion in disease pathogenesis, define the phenotype-genotype correlations between FECD and CTG18.1 expansion, and provide an update on research tools that are available to study FECD as a trinucleotide repeat expansion disease. Furthermore, ongoing international research efforts to develop novel CTG18.1 expansion-mediated FECD therapeutics are highlighted and we provide a forward-thinking perspective on key unanswered questions that remain in the field.

Type: Article
Title: TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat associated disease
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.preteyeres.2020.100883
Publisher version: https://doi.org/10.1016/j.preteyeres.2020.100883
Language: English
Additional information: This is an Open Access article published under a Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/).
Keywords: CTG18.1, FECD, Fuchs endothelial corneal dystrophy, RAN translation, RNA toxicity, Repeat-expansion, Transcription factor 4, Trinucleotide repeat, Triplet repeat-mediated disease
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery.ucl.ac.uk/id/eprint/10107482
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item